Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date

Wajd Alkabbani, John-Michael Gamble School of Pharmacy, Faculty of Science, University of Waterloo, Kitchener, ON, CanadaCorrespondence: John-Michael GambleSchool of Pharmacy, Faculty of Science, University of Waterloo, 10A Victoria Street S, Kitchener, ON, N2G 1C5, CanadaTel +1 519 888 4567Fax +1 5...

Full description

Saved in:
Bibliographic Details
Main Authors: Alkabbani W (Author), Gamble JM (Author)
Format: Book
Published: Dove Medical Press, 2021-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available